Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7779]

SABCS 2012: Combination of investigational agent and letrozole demonstrated clinical benefit in advanced ER-positive breast cancer

SABCS 2012: Combination of investigational agent and letrozole demonstrated clinical benefit in advanced ER...

SABCS 2012: Higher doses of fulvestrant prolonged survival in patients with advanced breast cancer

SABCS 2012: Higher doses of fulvestrant prolonged survival in patients with advanced breast cancer

Crizotinib launched in UK for patients with previously treated ALK-positive advanced NSCLC

Crizotinib launched in UK for patients with previously treated ALK-positive advanced NSCLC

FDA approves cabozantinib for the treatment of patients with progressive metastatic medullary thyroid cancer (MTC)

FDA approves cabozantinib for the treatment of patients with progressive metastatic medullary thyroid cancer (MTC)

Metformin may help ovarian cancer

Metformin may help ovarian cancer

Stem cell finding could advance immunotherapy for lung cancer

Stem cell finding could advance immunotherapy for lung cancer

Newly discovered effects of vitamin D on cancer

Newly discovered effects of vitamin D on cancer

Ponatinib acts against the most resistant types of chronic myeloid leukaemia

Ponatinib acts against the most resistant types of chronic myeloid leukaemia

Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer

Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

More from ecancer